---
title: 'Chronic graft-versus-host disease: Unresolved complication or ancient history?'
date: '2024-07-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39008818/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240716183635&v=2.18.0.post9+e462414
source: Blood
description: Chronic graft-vs.-host disease (GVHD) is associated with morbidity, mortality,
  impaired quality of life, prolonged immunosuppressive (IS) therapy, and infection
  risk after allogeneic hematopoietic cell transplantation (HCT). Major strides have
  occurred in the understanding of chronic GVHD biology, NIH Consensus meetings have
  refined rigorous approaches to diagnosis, staging and response criteria, major interventional
  trials have established standard benchmarks for treatment outcome, and ...
disable_comments: true
---
Chronic graft-vs.-host disease (GVHD) is associated with morbidity, mortality, impaired quality of life, prolonged immunosuppressive (IS) therapy, and infection risk after allogeneic hematopoietic cell transplantation (HCT). Major strides have occurred in the understanding of chronic GVHD biology, NIH Consensus meetings have refined rigorous approaches to diagnosis, staging and response criteria, major interventional trials have established standard benchmarks for treatment outcome, and ...